Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients

Leila Aghili, Jasmine Foo, James DeGregori, Subhajyoti De

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Little is understood about the occurrence of somatic genomic alterations in normal tissues and their significance in the context of disease. Here, we identified potential somatic copy number alterations (pSCNAs) in apparently normal ovarian tissue and peripheral blood of 423 ovarian cancer patients. There were, on average, two to four pSCNAs per sample detectable at a tissue-level resolution, although some individuals had orders of magnitude more. Accordingly, we estimated the lower bound of the rate of pSCNAs per cell division. Older individuals and BRCA mutation carriers had more pSCNAs than others. pSCNAs significantly overlapped with Alu and G-quadruplexes, and the affected genes were enriched for signaling and regulation. Some of the amplification/deletion hotspots in pan-cancer genomes were hot spots of pSCNAs in normal tissues as well, suggesting that those regions might be inherently unstable. Prevalence of pSCNA in peripheral blood predicted survival, implying that mutations in normal tissues might have consequences for cancer patients.

Original languageEnglish (US)
Pages (from-to)1310-1319
Number of pages10
JournalCell reports
Issue number4
StatePublished - May 22 2014

Bibliographical note

Funding Information:
The authors thank Rich White, Brent Pedersen, Madan Babu, Vinod Yadav, and the anonymous reviewers for providing helpful comments on the manuscript. S.D. gratefully acknowledges support from the American Cancer Society (ACS IRG 57-001-53), Lung Cancer Colorado Fund, and United Against Lung Cancer grant (sponsored by Elliot’s Legacy and Joan’s Legacy). J.D. gratefully acknowledges support from the NIH (R01CA180175).


Dive into the research topics of 'Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients'. Together they form a unique fingerprint.

Cite this